| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4de36eaaa471d491a1c3f2ae25eaef97 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 |
| filingDate |
2001-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04bece6f3070888f13b8db4989e94721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70306b710f9d737856ad2ae4b0c550c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4455ab1b9b99b887e644ec202f8ced9b |
| publicationDate |
2003-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1281325-A1 |
| titleOfInvention |
Nutritional composition preventing bacterial overgrowth |
| abstract |
Protein hydrolyzates are used for prevention of bacterial overgrowth. In additionnit was shown in sucklings mammals that specific protein hydrolyzates promotenan intestinal flore pattern which is similar to the one of mammals raised by theirnmother. Other advantages are that the hydrolyzate is easier to obtain and simplernto administrate than treatment of bacterial overgrowth with the aid of activenprinciples. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112512-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112509-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394370-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2382874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884033-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112509-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9271958-B2 |
| priorityDate |
2001-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |